LENALIDOMIDE
lenalidomide 20 mg capsule, 21
LENALIDOMIDE (14616G)
14616G
Manner of administration:Oral
Restriction
Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Triple combination therapy consisting of elotuzumab, lenalidomide and dexamethasone
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 21 | # of repeats: 2 | DPMQ: $757.74 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||